United Kingdom

People: Airbus SE (AIR.PA)

AIR.PA on Paris Stock Exchange

19 Jul 2019
Change (% chg)

€-0.60 (-0.45%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Clamadieu, Jean-Pierre 

Mr. Jean-Pierre Clamadieu has served as Non-Executive Independent Director of Airbus SE since April 11, 2018. He graduated (1981) from Ecole Nationale Superieure des Mines de Paris before becoming Chief Engineer of the Corps of Mines. Between 1981 - 1993, he worked mainly for the French Ministry of lndustry and as Technical Advisor to the Minister of Labor. In 1993, he joined RhonePoulenc to develop new activities in the field of automobile pollution control. ln the following years, he held several executive positions in the Rhodia group, as President of Rhodia's Chemicals in Latin America, President of Rhodia Eco Services, Senior VicePresident for Rhodia Corporate Purchasing, President of Rhodia Organic Fine Chemicals division and President of Rhodia Pharmaceuticals & Agrochemicals division. In October 2003, he was appointed CEO of Rhodia, and became its chairman & CEO in March 2008. Following a merger between Rhodia and the Belgian chemical group Solvay in 2011, he was appointed CEO of the new Solvay group. Since his appointment, he led the integration of the new group and its transformation into a major player in the field of specialty chemicals and advanced materials, which combines industrial competitiveness with the quest for sustainable solutions for its clients. He also promotes an ambitious and coordinated European energy policy. Current mandates: CEO and Member of the Board of Solvay SA, Member of the Board of Axa, Member of the Board of Solvay Finances SA (Luxembourg), Member of the Board of Solvay Specialty Chemicals Asia Pacific Pte.Ltd (Singapore). He has served as Remuneration, Nomination and Governance Committee of the Company since April 11, 2018.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --